2-[(3-Hexadecanoyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 甘油磷脂
• 英文名称: 2-[(3-Hexadecanoyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
• 化学式: C38H77NO8P+
• 分子量: 707.0
• InChiKey: UIXXHROAQSBBOV-UHFFFAOYSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  12.5
• 重原子数：
  48
• 可旋转键数：
  38
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  108
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• IMMUNOGENIC AMPHIPATHIC PEPTIDE COMPOSITIONS
  申请人：O'Hagan Derek

  公开号：US20110250237A1

  公开（公告）日：2011-10-13

  The present application pertains to a composition, comprising (a) amphipathic peptides; (b) lipids and (c) at least one immunogenic species. Respective compositions are suitable for immunogenic species transport and delivery, for example for systemic or local delivery to a mammal. Also provided are pharmaceutical compositions, comprising respective compositions. Methods of forming the foregoing are also provided.

  本申请涉及一种组合物，包括（a）两性胜肽；（b）脂质和（c）至少一种免疫原物种。各自的组合物适用于免疫原物种的运输和传递，例如用于系统性或局部传递到哺乳动物。还提供了药物组合物，包括各自的组合物。还提供了形成上述组合物的方法。
• LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF
  申请人：Ludwig Institute for Cancer Research, Ltd.

  公开号：EP2654779B1

  公开（公告）日：2018-02-28
• ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
  申请人：L.E.A.F Holdings Group LLC

  公开号：EP3749313A1

  公开（公告）日：2020-12-16
• CAROTENOID COMPOSITIONS AND USES THEREOF
  申请人：L.E.A.F Holdings Group LLC

  公开号：EP3787607A1

  公开（公告）日：2021-03-10
• METHOD
  申请人：Larsen Niels Erik

  公开号：US20120231116A1

  公开（公告）日：2012-09-13

  A method of producing powder milk, said method comprising: (a) contacting milk or a fraction thereof with a lipid acyltransferase enzyme; and (b) drying the enzyme treated milk to produce powder milk; is disclosed. Powder milk products produced by the method and use of a lipid acyltransferase in the manufacture of powder milk for improving the rehydration properties, the perceptible sensory difference (smell and/or taste) and the flowability of the powder milk, and for reducing the cholesterol content and/or the free fatty acid content of the powder milk, and for reducing fouling of the equipment used in the manufacture of the powder milk, are also disclosed.